TA Associates-backed OmniActive explores $200-300 million IPO at $1 bn valuation
Indian markets moved higher in an ipo & listings development.
· LiveMint Companies
The IPO plan follows several unsuccessful attempts to raise private capital, as macroeconomic headwinds and geopolitical conflicts weighed on investor sentiment. If the IPO goes as planned, it would make OmniActive the first pure-play nutraceutical company to list on the exchanges.
The analysis
Listing activity is a read on risk appetite — a hot primary market usually means a confident secondary one.
Market context
- Sector exposure: Capital Goods & Engineering, Capital Markets.
In this story
Related coverage
Vaibhav Vyapaar Shares to list today; Check GMP ahead of debut
SFC Environmental Technologies IPO opens Oct 27, price band at ₹313-330
Jio IPO strengthens Reliance’s financial flexibility; capex funding remains key: Moody’s
Jio IPO: Nithin Kamath explains how Jio played an important role in making what Zerodha is today
JSW Steel Q2 results preview: Adj. PAT could grow 60-110% YoY, say analysts